Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

• Other Authors: Ferroni, Patrizia (Editor), Roselli, Mario (Editor), Guadagni, Fiorella (Editor)
• Format: Electronic Book Chapter
• Language: English
• Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Subjects: Medicine; Oncology; multiple myeloma; venous thromboembolism; risk assessment models; thromboprophylaxis; direct oral anticoagulants; cancer-associated venous thromboembolism; thrombosis; pulmonary embolism; neoplasms; anticoagulants; coumarins; low molecular weight heparins; cancer; endogenous heparin; heparanase; heparan sulfate; hospice; palliative care units; low molecular weight heparin; deep vein thrombosis; cancer associated thrombosis; VTE; malignancy; direct oral anticoagulant; pancreatic cancer; low-molecular weight heparin; survival; coagulation activation; locally advanced breast cancer; prognostic model; pCR; treatment; prophylaxis; DOAC; simultaneous care; integrated care; lymphoma; Non-Hodgkin lymphoma; Hodgkin lymphoma; risk factors; molecular subtype; arterial thrombosis; ALK; ROS1; KRAS; chemotherapy; low-molecular-weight heparin (LMWH); VKA; UFH; DOACs; n/a
• Online Access: DOAB: download the publication; DOAB: description of the publication

Thromboembolism is a compelling challenge in cancer care because of its life-threatening nature as well as its impact on specific treatments. Current guidelines do not generally recommend antithrombotic prophylaxis, except in selected categories of patients at high risk of thrombosis. Accordingly, s...